01—Abstract
Summary
Summary of the 10-Q filed August 1, 2024. Cited figures are marked; the original filing is the authoritative source.
Corteva, Inc. reported solid results for the second quarter of 2024, demonstrating resilience and strategic execution.
Net sales increased by 1% year-over-year to $6.112 billiona, driven by a 2% price increase that offset a 1% unfavorable impact from portfolio and other changes, while volumes remained flat overall. The Seed segment showed particular strength, with net sales up 2% driven by strong pricing and a favorable product mix, contributing significantly to a 16% increase in segment operating EBITDA. This segment is outperforming the market and gaining share, underscoring the value of its advanced germplasm and trait technologies.
While the Crop Protection segment's net sales were flat year-over-year, driven by increased volumes in certain areas offset by price declines and currency headwinds, its segment operating EBITDA decreased by 20%b. This was attributed to competitive pricing and raw material cost inflation, despite productivity savings and volume growth.
The company continues to navigate a challenging market environment in Crop Protection but expects elevated input costs to subside in the second half of 2024. Overall, Corteva reiterated its full-year 2024 outlook for net sales and Operating EBITDA, signaling confidence in its strategic direction and operational capabilities.
02—Key points
Key Highlights
- Net sales increased 1% to $6.112 billion in Q2 2024, driven by a 2% price increase.
- Seed segment net sales grew 2% to $4.331 billion, with segment operating EBITDA up 16% to $1.698 billion, indicating strong pricing and market share gains.
- Crop Protection segment net sales remained flat year-over-year at $1.781 billion, with segment operating EBITDA decreasing 20% due to pricing pressures and inflation.
- The company maintained its full-year 2024 outlook for net sales ($17.2B - $17.5B) and Operating EBITDA ($3.4B - $3.6B).
- Corteva announced a 6.25% increase in its common stock dividend to $0.17 per share.
- Share repurchases continued, with $250 million repurchased in Q2 2024 under the $2 billion share buyback program.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2024filed August 1, 2024Financial Statements
Q2 FY2024 against Q2 FY2023
| Line item | Q2 FY2024Q2 FY2023 | Change |
|---|---|---|
| Revenue | $6.11B$6.04B | +1.1% |
| Cost of Revenue | $2.92B$3.14B | −7.0% |
| Gross Profit | $3.19B$2.91B | +9.8% |
| R&D Expenses | $357.00M$329.00M | +8.5% |
| SG&A Expenses | $1.05B$1.04B | +0.9% |
| Net Income | $1.06B$714.00M | +47.9% |
| EPS (Basic) | $1.51$1.00 | +51.0% |
| EPS (Diluted) | $1.51$1.00 | +51.0% |
| Shares Outstanding (Basic) | 695.90M710.80M | −2.1% |
| Shares Outstanding (Diluted) | 698.10M713.70M | −2.2% |
05—Questions
Frequently Asked Questions
How did Corteva's revenue perform in the second quarter of 2024 compared to the same period last year?
Corteva's net sales increased by 1% to $6.112 billion in the second quarter of 2024, compared to $6.045 billion in the second quarter of 2023. This growth was primarily driven by a 2% increase in price, which offset a 1% unfavorable impact from portfolio and other changes. Overall volume remained flat.
What was the performance of the Seed and Crop Protection segments?
The Seed segment demonstrated strong performance, with net sales increasing by 2% to $4.331 billion and segment operating EBITDA rising by 16% to $1.698 billion. This was driven by price execution, favorable product mix, and ongoing cost efficiencies. The Crop Protection segment saw flat net sales at $1.781 billion, but its segment operating EBITDA decreased by 20% to $255 million, impacted by competitive pricing, raw material cost inflation, and unfavorable currency impacts, despite volume increases and productivity savings.
Did Corteva provide an updated full-year financial outlook?
Yes, Corteva reiterated its full-year 2024 outlook, expecting net sales between $17.2 billion and $17.5 billion, and Operating EBITDA in the range of $3.4 billion to $3.6 billion. Operating Earnings Per Share is projected to be between $2.60 and $2.80.
What actions is Corteva taking regarding shareholder returns?
Corteva announced a 6.25% increase in its common stock dividend to $0.17 per share, payable in September 2024. Additionally, the company continued its share repurchase program, buying back $250 million worth of shares in the second quarter of 2024 under its $2 billion authorization.
06—Continue